Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

CUSIP: 03237H101

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
+10,456,035
Put/Call ratio
59%
SEC-reported price per share
$28.15
Number of holders
90
Value change
+$315,174,073
Number of buys
66
Open additional details 1 more signal available
Number of sells
31
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
110,465,093

Security key

03237H101

Report period

Q3 2022

Institutions

90

Top holders

10

Ownership snapshot

Top reported holders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F 3/4/5 Lead comparable stake: 6.5% Showing 1-6 of 15 holder rows.

Quick read

VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 6.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership Top 5
VIKING GLOBAL INVESTORS LP 6.5%
PERCEPTIVE ADVISORS LLC 3.2%
Boxer Capital, LLC 2%
Bain Capital Life Sciences Invest... 1.8%
VANGUARD GROUP INC 0.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VIKING GLOBAL INVESTORS LP
13F 3/4/5
Company · 10%+ Owner
6.5%
$138,105,000
7,170,536 shares
30 Jun 2022
PERCEPTIVE ADVISORS LLC
13F
Company
13F
3.2%
$68,188,000
3,540,408 shares
30 Jun 2022
Boxer Capital, LLC
13F
Company
13F
2%
$42,372,000
2,200,000 shares
30 Jun 2022
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
1.8%
$37,523,000
1,948,214 shares
30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
0.9%
$19,145,000
994,001 shares
30 Jun 2022
Rock Springs Capital Management LP
13F
Company
13F
0.88%
$18,761,000
974,107 shares
30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
90
Shares
36,858,311
Rows available
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
74
Q3 2022 holders
90
Holder diff
16
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .